Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. (Q43875313)

27 November 2017

Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. (English)

1 reference

Mycobacterium avium avium

27 November 2017

1 reference

1 reference

1 reference

Yuji Shiraishi

1

1 reference

27 November 2017

Yutsuki Nakajima

2

1 reference

27 November 2017

Keiichiro Takasuna

3

1 reference

27 November 2017

Takaomi Hanaoka

4

1 reference

27 November 2017

Naoya Katsuragi

5

1 reference

27 November 2017

Hidehiro Konno

6

1 reference

27 November 2017

1 February 2002

1 reference

European Journal of Cardio-Thoracic Surgery

27 November 2017

1 reference

27 November 2017

21

1 reference

27 November 2017

2

1 reference

27 November 2017

314-318

1 reference

First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

Results of operation in Mycobacterium avium-intracellulare lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

Nontuberculous mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

Surgical management of pulmonary disease due to Mycobacterium avium-intracellulare.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Long-term results of pulmonary resection for atypical mycobacterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Early pulmonary resection for localized Mycobacterium avium complex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-M. intracellulare infection

1 reference

https://api.crossref.org/works/10.1016%2FS1010-7940%2801%2901122-8

7 January 2021

10.1016/S1010-7940(01)01122-8

Identifiers

DOI

1 reference

27 November 2017

1 reference